Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience A. Martínez-Doménech, V. Zaragoza-Ninet, A. Esteve-Martínez, A. García-Rabasco, J.L. Sánchez-Carazo, A. Pérez-Ferriols

Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series F.J. Melgosa Ramos, T. Díaz Corpas, S. Martín Jiménez, A. Mateu Puchades

Atopic Dermatitis Patient With Hepatitis C Treated With Dupilumab—A Case Report F. Mota